Syncope pp 237-250 | Cite as

Unexplained Syncope in Patients with High Risk of Sudden Cardiac Death



In patients at high risk of sudden cardiac death (SCD), a disease-specific treatment is essential in order to reduce risk of death and of life-threatening events, even if the exact mechanism of syncope is still unknown or uncertain at the end of a complete workup. In these patients the goal of treatment is primarily the reduction of mortality risk.


Ventricular Tachycardia Sudden Cardiac Death Arrhythmogenic Right Ventricular Cardiomyopathy Ventricular Tachyarrhythmia Brugada Syndrome 


  1. 1.
    Olshansky B, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282.PubMedCrossRefGoogle Scholar
  2. 2.
    Vardas PE, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2007;28:2256–2295.PubMedCrossRefGoogle Scholar
  3. 3.
    Goldberger JJ, et al. Scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. Circulation. 2008;118:1497–1518.PubMedCrossRefGoogle Scholar
  4. 4.
    Epstein AE, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51:e1–e62.PubMedCrossRefGoogle Scholar
  5. 5.
    Zipes DP, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace. 2006;8:746–837.PubMedCrossRefGoogle Scholar
  6. 6.
    Steinberg JS, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001;12:996–1001.PubMedCrossRefGoogle Scholar
  7. 7.
    Andrews NP, et al. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol. 1999;34:2023–2030.PubMedCrossRefGoogle Scholar
  8. 8.
    Brembilla-Perrot B, et al. Differences in mechanism and outcomes of syncope patients with coronary artery disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing. J Am Coll Cardiol. 2004;44:594–601.PubMedCrossRefGoogle Scholar
  9. 9.
    Middlekauff HR, et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993;21:110–116.PubMedCrossRefGoogle Scholar
  10. 10.
    Alboni P, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001;37:1921–1928.PubMedCrossRefGoogle Scholar
  11. 11.
    Menozzi C, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002;105:2741–2745.PubMedCrossRefGoogle Scholar
  12. 12.
    Spirito P, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703–1710.PubMedCrossRefGoogle Scholar
  13. 13.
    Elliott P, McKenna W. The science of uncertainty and the art of probability: syncope and its consequences in hypertrophic cardiomyopathy. Circulation. 2009;119:1697–1699.PubMedCrossRefGoogle Scholar
  14. 14.
    Maron BJ, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;42:1687–1713.PubMedCrossRefGoogle Scholar
  15. 15.
    Frenneaux MP. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart. 2004;90:570–575.PubMedCrossRefGoogle Scholar
  16. 16.
    Williams L, Frenneaux M. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Europace. 2007;9:817–822.PubMedCrossRefGoogle Scholar
  17. 17.
    Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm. 2009;6:984–992.PubMedCrossRefGoogle Scholar
  18. 18.
    Hulot JS, et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2004;110:1879–1884.PubMedCrossRefGoogle Scholar
  19. 19.
    Dalal D, et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation. 2005;112:3823–3832.PubMedCrossRefGoogle Scholar
  20. 20.
    Corrado D, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–3091.PubMedCrossRefGoogle Scholar
  21. 21.
    Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–2671.PubMedCrossRefGoogle Scholar
  22. 22.
    Goldenberg J, Moss A. Long QT syndrome. J Am Coll Cardiol. 2008;51:2291–2300.PubMedCrossRefGoogle Scholar
  23. 23.
    Roden DM. Clinical practice. Long-QT syndrome. N Engl J Med. 2008;358:169–176.PubMedCrossRefGoogle Scholar
  24. 24.
    Antzelevitch C, et al. Brugada syndrome: report of the second consensus conference. Circulation. 2005;111:659–670.PubMedCrossRefGoogle Scholar
  25. 25.
    Paul M, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126–2133.PubMedCrossRefGoogle Scholar
  26. 26.
    Morita H, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation. 2008;118:1697–1704.PubMedCrossRefGoogle Scholar
  27. 27.
    Sacher F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114:2317–2324.PubMedCrossRefGoogle Scholar
  28. 28.
    Rosso R, et al. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J. 2008;10:435–439.PubMedGoogle Scholar
  29. 29.
    Probst V, et al. Long-term prognosis of patients diagnosed with Brugada syndrome. Results from the FINGER Brugada Syndrome Registry. Circulation. 2010;121:635–643.Google Scholar
  30. 30.
    Hayashi M, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation. 2009;119:2426–2434.PubMedCrossRefGoogle Scholar
  31. 31.
    Gaita F, et al. Short QT syndrome: A familial cause of sudden death. Circulation. 2003;108:965–970.PubMedCrossRefGoogle Scholar
  32. 32.
    Brignole M. Are complications of implantable defibrillators under-estimated and benefits over-estimated?. Europace. 2009;11:1129–1133.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Dipartimento di Cardiologia, Centro AritmologicoOspedali del TigullioLavagnaItaly
  2. 2.Cardiac Arrhythmia CenterMedical School, University of MinnesotaMinneapolisUSA

Personalised recommendations